Literature DB >> 72598

Surface antigenic characteristics of human glial brain tumor cells.

C J Wikstrand, M S Mahaley, D D Bigner.   

Abstract

The surface antigenic characteristics of human glial brain tumor (HGBT) cells were studied by complement-dependent cytotoxic antibody assays and indirect membrane immunofluorescence. Eight permanent, well-characterized cell lines derived from human gliomas were used for analysis with antisera raised by hyperimmunization of nonhuman primates (Macaca fascicularis) with glioblastoma multiforme tissue or established HGBT cells lines. Exhaustive absorption of these antisera to remove predominantly antispecies activity rendered HLA nonreactive "preabsorbed" antisera, which reacted with a large panel of gliomatous and nongliomatous human tumor cells; 1 carcinoma, 2 sarcomas, 2 melanomas, 1 neuroblastoma, and 8 HGBT cell lines. Four lymphoblastoid lines and 2 carcinomas were unreactive. After further absorption with a human osteogenic sarcoma cell line, the antisera demonstrated significant levels of reactivity for 8 tested HGBT cell lines and no longer reacted with the nongliomatous cultured tumor cells lines. Therefore, extensive absorption of nonhuman primate anti-human glioma sera removed all activity for the nongliomatous cell lines tested, but it left significant reactivity against a glial tumor cell line-associated antigen(s) present on all 8 human glioma cell lines tested.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72598

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Immunobiology of brain tumors.

Authors:  E Frank; N de Tribolet
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

Review 2.  The immunobiology of human gliomas.

Authors:  V Piguet; A C Diserens; S Carrel; J P Mach; N de Tribolet
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Growth of measles virus in continuous cell lines derived from the nervous tissues of human and rat.

Authors:  K Kobune; K Yamanouchi; Y Yoshikawa; M Hayami; A Shishido
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

Review 4.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

5.  Morphologic, cytochemical and neurochemical characterization of the human medulloblastoma cell line TE671.

Authors:  P M Zeltzer; S L Schneider; D D Von Hoff
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 6.  Immunology of gliomas.

Authors:  N de Tribolet
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

7.  Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Authors:  D C Longee; C J Wikstrand; J E Månsson; X He; G N Fuller; S H Bigner; P Fredman; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 8.  Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Authors:  John H Sampson; Gary E Archer; Duane A Mitchell; Amy B Heimberger; Darell D Bigner
Journal:  Semin Immunol       Date:  2008-06-09       Impact factor: 11.130

9.  Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study.

Authors:  P Steinbok; J P Thomas; L Grossman; C L Dolman
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

10.  Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.

Authors:  H S Friedman; P C Burger; S H Bigner; J Q Trojanowski; G M Brodeur; X M He; C J Wikstrand; J Kurtzberg; M E Berens; E C Halperin
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.